[Hexoprenalin as a tocolytic drug (author's transl)]

Area of Science:

• Obstetrics and Gynecology
• Pharmacology

Context:

• Premature labor poses significant risks to both mother and infant.
• Tocolytic agents are crucial for managing preterm labor.
• Hexoprenalin is a beta-sympathomimetic drug with potential tocolytic properties.

Purpose:

• To evaluate the tocolytic efficacy of hexoprenalin.
• To assess cardiovascular side effects of hexoprenalin at different dosages.
• To compare hexoprenalin's effects in prophylaxis versus inhibition of premature labor.

Summary:

• Hexoprenalin was administered intravenously via long-term infusion for tocolysis.
• Two dosage regimens were used: 0.075 µg/min for prophylaxis and 0.33 µg/min for inhibition.
• Both regimens demonstrated satisfactory tocolytic effects with acceptable cardiovascular side effect profiles.

Impact:

• Hexoprenalin shows promise as an effective tocolytic agent in managing premature labor.
• Understanding dosage-dependent cardiovascular effects is crucial for safe clinical application.
• Further research may establish hexoprenalin as a standard treatment option in obstetrics.